V. Salmonehr et al., EXPRESSION OF INTERLEUKIN-4 IN SCLERODERMA SKIN SPECIMENS AND SCLERODERMA FIBROBLAST-CULTURES - POTENTIAL ROLE IN FIBROSIS, Archives of dermatology, 132(7), 1996, pp. 802-806
Background: Scleroderma (systemic sclerosis) is a fibrotic disease cha
racterized by an uncontrolled tissular accumulation of collagen. Sever
al cytokines have been implicated in the fibroblast activation leading
to fibrosis. For instance, we have previously demonstrated that inter
leukin-4 (IL-4) is a potent activator of collagen synthesis in fibrobl
ast cultures. In this study, using immunocytochemical methods and in s
itu hybridization, we investigated the expression of IL-4 in normal an
d scleroderma skin and fibroblast cultures. Observations: Immunocytoch
emical studies with anti-IL-4 antibody were performed on biopsy specim
ens from 9 patients with normal skin and 11 patients with scleroderma.
The label was intense or strong in 8 of the 11 scleroderma skin speci
mens, whereas it was negative or faint in 8 of the 9 normal skin speci
mens (P<.01). In situ hybridization demonstrated a significant increas
e of the number of IL-4 messenger RNA grains in scleroderma skin compa
red with normal skin (3.1+/-1.5 [mean+/-SD] vs 0.8+/-0.7; P<.001). A s
trongly positive labeling with the anti-IL-4 antibody was found in the
4 scleroderma fibroblast cultures, whereas it was negative in the 5 f
ibroblast control cultures (P<.05). Conclusions: Our results demonstra
te that IL-4 is strongly expressed in the dermis of a large majority o
f patients with scleroderma and might be synthesized by scleroderma fi
broblasts. We suggest that IL-4 is one of the cytokines implicated in
the early steps of the fibrotic process.